This dataset contains raw high-resolution mass spectrometry data from a randomized controlled trial evaluating probiotic supplementation in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) (ClinicalTrials.gov Identifier: NCT04555434). Participants received placebo or probiotic capsules containing Pediococcus pentosaceus, Lactobacillus lactis, or Lactobacillus helveticus for 8 weeks.
Fecal samples collected before and after intervention from participants with high medication adherence (at least 98%) were analyzed using untargeted metabolomic and lipidomic profiling. The data capture probiotic-associated alterations in fecal metabolites and lipid species related to gut-liver axis modulation and hepatic function.
[doi:10.25345/C53J39F33]
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: MASLD ; Probiotics ; Lipidomics ; DatasetType:Metabolomics
|
Principal Investigators: (in alphabetical order) |
Hyeon-Seong Lee, Korea Institute of Science and Technology;KIST, Republic of Korea |
| Submitting User: | Hyeonseong |
| Number of Files: | |
| Total Size: | |
| Spectra: | |
| Subscribers: | |
| Owner | Reanalyses | |
|---|---|---|
| Experimental Design | ||
|
Conditions:
|
||
|
Biological Replicates:
|
||
|
Technical Replicates:
|
||
| Identification Results | ||
|
Proteins (Human, Remapped):
|
||
|
Proteins (Reported):
|
||
|
Peptides:
|
||
|
Variant Peptides:
|
||
|
PSMs:
|
||
| Quantification Results | ||
|
Differential Proteins:
|
||
|
Quantified Proteins:
|
||
| Browse Dataset Files | |
|
FTP Download Link (click to copy):
|